Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan
· Delayed Price · Currency is TWD 45.10
-0.20 (-0.44%)
At close: Apr 29, 2026
Yoda Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 325.38 | 569.11 | 34.77 | 19.2 |
| Short-Term Investments | - | 54.74 | 296.97 | - |
| Cash & Short-Term Investments | 325.38 | 623.85 | 331.74 | 19.2 |
| Cash Growth | -47.84% | 88.06% | 1627.52% | - |
| Other Receivables | 0.88 | 2.31 | 2.34 | 0.07 |
| Receivables | 0.88 | 2.31 | 2.34 | 0.07 |
| Prepaid Expenses | 2.95 | 4.28 | 10.71 | 0.81 |
| Other Current Assets | 669.4 | 0 | - | - |
| Total Current Assets | 998.61 | 630.45 | 344.78 | 20.08 |
| Property, Plant & Equipment | 3.2 | 4.68 | 1.49 | 0.44 |
| Other Intangible Assets | 8.27 | 9.25 | 9.25 | 9.84 |
| Other Long-Term Assets | 7.4 | 0.08 | 3.04 | 0.01 |
| Total Assets | 1,017 | 644.45 | 358.57 | 30.36 |
| Accrued Expenses | 17.52 | 13.21 | 22.02 | 2.49 |
| Current Portion of Long-Term Debt | - | - | - | 9.23 |
| Current Portion of Leases | 0.81 | 0.79 | - | - |
| Other Current Liabilities | 12.47 | 3.55 | 0.81 | 0.89 |
| Total Current Liabilities | 30.8 | 17.55 | 22.83 | 12.6 |
| Long-Term Leases | - | 0.81 | - | - |
| Other Long-Term Liabilities | 2.66 | - | - | - |
| Total Liabilities | 33.46 | 18.36 | 22.83 | 12.6 |
| Common Stock | 793.88 | 773.88 | 0.19 | 0.24 |
| Additional Paid-In Capital | 273.18 | 194.45 | 501.83 | 112.86 |
| Retained Earnings | -779.1 | -371.88 | -179.68 | -94.36 |
| Treasury Stock | - | - | - | -0.47 |
| Comprehensive Income & Other | 696.06 | 29.64 | 12.75 | -0.67 |
| Total Common Equity | 984.02 | 626.09 | 335.09 | 17.6 |
| Shareholders' Equity | 984.02 | 626.09 | 335.74 | 17.76 |
| Total Liabilities & Equity | 1,017 | 644.45 | 358.57 | 30.36 |
| Total Debt | 0.81 | 1.6 | - | 9.23 |
| Net Cash (Debt) | 324.57 | 622.25 | 331.74 | 9.97 |
| Net Cash Growth | -47.84% | 87.57% | 3226.00% | - |
| Net Cash Per Share | 4.10 | 14.58 | 27.86 | 0.85 |
| Filing Date Shares Outstanding | 79.39 | 77.39 | 79.39 | 11.67 |
| Total Common Shares Outstanding | 79.39 | 77.39 | 11.98 | 11.67 |
| Working Capital | 967.81 | 612.9 | 321.95 | 7.48 |
| Book Value Per Share | 12.40 | 8.09 | 27.96 | 1.51 |
| Tangible Book Value | 975.76 | 616.85 | 325.84 | 7.76 |
| Tangible Book Value Per Share | 12.29 | 7.97 | 27.19 | 0.67 |
| Machinery | 4.16 | 3.77 | 2.06 | 0.76 |
Source: S&P Capital IQ. Standard template. Financial Sources.